Brief: Spero Therapeutics Appoints Sath Shukla As President, CEO

Spero Therapeutics

14/06/2023 13:58

June 14 (Reuters) - Spero Therapeutics Inc  SPRO.O :
    * SPERO THERAPEUTICS APPOINTS SATH SHUKLA AS PRESIDENT &
CHIEF
EXECUTIVE OFFICER
    * SPERO THERAPEUTICS INC - CURRENT PRESIDENT AND CHIEF
EXECUTIVE
OFFICER, ANKIT MAHADEVIA, M.D TO BECOME CHAIRMAN OF BOARD OF
DIRECTORS
    * SPERO THERAPEUTICS INC - CURRENT PRESIDENT AND CHIEF
EXECUTIVE
OFFICER, ANKIT MAHADEVIA, M.D TO BECOME CHAIRMAN OF BOARD OF
DIRECTORS
    * SPERO THERAPEUTICS INC - CURRENT CHAIRMAN OF BOARD, MILIND
DESHPANDE WILL REMAIN ON BOARD AS AN INDEPENDENT DIRECTOR
    * SPERO THERAPEUTICS INC - SATH SHUKLA APPOINTED CEO, TO BE
EFFECTIVE AUGUST 1, 2023
    * SPERO THERAPEUTICS INC - HAS NOW LAUNCHED A SEARCH FOR
NEXT CFO
TO SUCCEED  SHUKLA
    * SPERO THERAPEUTICS INC - UNTIL THIS SEARCH IS COMPLETED,
BOARD
HAS APPOINTED STEPHEN J. DIPALMA AS INTERIM CFO AND TREASURER,
EFFECTIVE AUGUST 1, 2023
    * SPERO THERAPEUTICS INC - BOARD HAS APPOINTED STEPHEN J.
DIPALMA
AS INTERIM CFO AND TREASURER, EFFECTIVE AUGUST 1, 2023

Source text for Eikon:  ID:nGNXVY2sj 
Further company coverage:  SPRO.O 

 (reuters.briefs@thomsonreuters.com)